Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Technomedics Norge AS
AS
Active
Org 986392742
Gramveien 68, 1832
Askim
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2004 · 22 years old
17 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Technomedics Norge AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
67M
50M
34M
17M
0M
2021: 39M
39M
2021
2022: 43M (+10% vs 2021)
43M
+10%
2022
2023: 44M (+2% vs 2022)
44M
+2%
2023
2024: 54M (+23% vs 2023)
54M
+23%
2024
2025: 53M (-2% vs 2024)
53M
-2%
2025
EBITDA
NOK millions
10M
7M
5M
2M
0M
2021: 7M
7M
2021
2022: 6M (-14% vs 2021)
6M
-14%
2022
2023: 6M (0% vs 2022)
6M
0%
2023
2024: 8M (+33% vs 2023)
8M
+33%
2024
2025: 7M (-12% vs 2024)
7M
-12%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
53 395
54 448
44 439
42 954
38 956
Staff expenses
−13 161
−14 095
−10 990
−10 455
−10 020
EBITDA
6 981
8 053
5 718
5 828
6 556
Depreciation & amort.
−511
−607
−611
−411
−319
EBIT
6 470
7 446
5 107
5 417
6 236
Net financials
162
152
43
82
27
Profit before tax
6 632
7 598
5 150
5 498
6 263
Tax
1 498
1 680
1 141
1 223
1 382
Net profit
5 134
5 918
4 009
4 276
4 880
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
19 774
23 355
17 271
18 739
20 173
Equity
6 084
6 049
6 032
6 023
5 997
Long-term debt
0
0
0
0
0
Short-term debt
13 690
17 306
11 239
12 716
14 176
Total debt
13 690
17 306
11 239
12 716
14 176
Financial ratios
5-year trend
EBITDA margin
13,1 %
This company
15,8 %
Market median
This company
Market median
17% below market
2021
2025
Equity ratio
30,8 %
This company
38,2 %
Market median
This company
Market median
19% below market
2021
2025
Return on equity
84,4 %
This company
18,4 %
Market median
This company
Market median
359% above market
2021
2025
Net profit margin
9,6 %
This company
8,1 %
Market median
This company
Market median
19% above market
2021
2025
Asset turnover
2,70×
This company
1,12×
Market median
This company
Market median
141% above market
2021
2025
Debt / equity
2,25×
This company
0,62×
Market median
This company
Market median
263% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Technomedics Norge AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
